咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Bisphosphonates Zoledronate an... 收藏

Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

作     者:IsraaIsraa Ahmed Radwan Nahed Sedky Korany Bassant Adel Ezzat 

作者机构:Department of Oral Biology Faculty of Oral and Dental Medicine Cairo University Cairo Egypt 

出 版 物:《Case Reports in Clinical Medicine》 (临床医学病理报告(英文))

年 卷 期:2018年第7卷第5期

页      面:324-342页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Bisphosphonates Alendronate Zoledronate Postmenopausal Osteoporosis 

摘      要:Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分